BC
RMTI icon

Broadfin Capital’s Rockwell Medical RMTI Stock Holding History

Broadfin Capital’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,801
Closed -$1.91M – 60
2013
Q2 		$1.91M Buy
+4,801
New +$2.04M 0.37% 46

Other funds holding RMTI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Broadfin Capital's RMTI Position: Q3 2013 in Review

Broadfin Capital sold out of Rockwell Medical (RMTI) in Q3 2013, closing a stake of 4,801 shares — an estimated $1.91M sold.

Broadfin Capital first reported a position in RMTI in Q2 2013 and held it in 1 quarter. The position peaked at $1.91M in Q2 2013. 83 funds tracked by Wall St. Rank hold RMTI as of Q3 2013.

  • Broadfin Capital reported no remaining Rockwell Medical position as of Q3 2013 after selling out during the quarter.
  • Broadfin Capital sold 4,801 Rockwell Medical shares in Q3 2013, an estimated $1.91M.
  • Broadfin Capital first reported a position in Rockwell Medical in Q2 2013 and held it in 1 quarter.
  • Broadfin Capital's Rockwell Medical position peaked at $1.91M in Q2 2013.
  • 83 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2013.

Based on Broadfin Capital's 13F filing for Q3 2013, filed 14 Nov 2013.